vs
Side-by-side financial comparison of American Express (AXP) and Beta Bionics, Inc. (BBNX). Click either name above to swap in a different company.
Beta Bionics, Inc. is the larger business by last-quarter revenue ($27.6M vs $18.9M, roughly 1.5× American Express). American Express runs the higher net margin — 15.7% vs -79.3%, a 95.0% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 11.4%).
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...
Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.
AXP vs BBNX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $27.6M |
| Net Profit | $3.0M | $-21.9M |
| Gross Margin | — | 59.5% |
| Operating Margin | — | -47.4% |
| Net Margin | 15.7% | -79.3% |
| Revenue YoY | 11.4% | 56.6% |
| Net Profit YoY | 15.0% | 23.6% |
| EPS (diluted) | — | $-0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.9M | $27.6M | ||
| Q4 25 | $10.9B | $32.1M | ||
| Q3 25 | $10.4B | $27.3M | ||
| Q2 25 | $10.3B | $23.2M | ||
| Q1 25 | $9.6B | $17.6M | ||
| Q4 24 | $10.0B | — | ||
| Q3 24 | $9.7B | — | ||
| Q2 24 | $9.8B | — |
| Q1 26 | $3.0M | $-21.9M | ||
| Q4 25 | $2.5B | $-13.5M | ||
| Q3 25 | $2.9B | $-14.2M | ||
| Q2 25 | $2.9B | $-16.9M | ||
| Q1 25 | $2.6B | $-28.7M | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $3.0B | — |
| Q1 26 | — | 59.5% | ||
| Q4 25 | — | 59.0% | ||
| Q3 25 | — | 55.5% | ||
| Q2 25 | — | 53.8% | ||
| Q1 25 | — | 50.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | -47.4% | ||
| Q4 25 | 28.2% | -50.2% | ||
| Q3 25 | 36.7% | -62.5% | ||
| Q2 25 | 34.4% | -85.5% | ||
| Q1 25 | 34.6% | -105.7% | ||
| Q4 24 | 27.7% | — | ||
| Q3 24 | 33.0% | — | ||
| Q2 24 | 38.6% | — |
| Q1 26 | 15.7% | -79.3% | ||
| Q4 25 | 22.5% | -41.9% | ||
| Q3 25 | 27.9% | -52.1% | ||
| Q2 25 | 28.0% | -72.6% | ||
| Q1 25 | 26.8% | -162.5% | ||
| Q4 24 | 21.8% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 30.7% | — |
| Q1 26 | — | $-0.49 | ||
| Q4 25 | $3.52 | $-0.16 | ||
| Q3 25 | $4.14 | $-0.33 | ||
| Q2 25 | $4.08 | $-0.39 | ||
| Q1 25 | $3.64 | $-0.93 | ||
| Q4 24 | $3.04 | — | ||
| Q3 24 | $3.49 | — | ||
| Q2 24 | $4.15 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $199.5M |
| Total DebtLower is stronger | $60.4M | — |
| Stockholders' EquityBook value | $34.0M | $271.2M |
| Total Assets | $308.9M | $304.4M |
| Debt / EquityLower = less leverage | 1.78× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $199.5M | ||
| Q4 25 | $742.0M | $219.1M | ||
| Q3 25 | $1.3B | $228.7M | ||
| Q2 25 | $197.0M | $249.7M | ||
| Q1 25 | $261.0M | $231.5M | ||
| Q4 24 | $221.0M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $188.0M | — |
| Q1 26 | $60.4M | — | ||
| Q4 25 | $56.4B | — | ||
| Q3 25 | $57.8B | — | ||
| Q2 25 | $58.2B | — | ||
| Q1 25 | $51.2B | — | ||
| Q4 24 | $49.7B | — | ||
| Q3 24 | $53.5B | — | ||
| Q2 24 | $51.5B | — |
| Q1 26 | $34.0M | $271.2M | ||
| Q4 25 | $33.5B | $287.6M | ||
| Q3 25 | $32.4B | $294.8M | ||
| Q2 25 | $32.3B | $301.6M | ||
| Q1 25 | $31.2B | $313.8M | ||
| Q4 24 | $30.3B | — | ||
| Q3 24 | $29.7B | — | ||
| Q2 24 | $29.5B | — |
| Q1 26 | $308.9M | $304.4M | ||
| Q4 25 | $300.1B | $328.7M | ||
| Q3 25 | $297.6B | $330.0M | ||
| Q2 25 | $295.6B | $330.0M | ||
| Q1 25 | $282.2B | $338.0M | ||
| Q4 24 | $271.5B | — | ||
| Q3 24 | $271.0B | — | ||
| Q2 24 | $272.2B | — |
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.78× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.80× | — | ||
| Q2 24 | 1.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
BBNX
Segment breakdown not available.
